We’re excited to announce our partnership with Alamar Biosciences, bringing the revolutionary NULISA™ platform to India.
NULISA offers attomolar sensitivity in fluid biomarker detection-unlocking new possibilities in early disease diagnosis and precision medicine. By combining sequential immunocomplex capture with NGS, it enables ultra-sensitive, multiplexed proteomic analysis.
This Partnership empowers researchers across neurology, immunology, and oncology to detect even the most elusive biomarkers, filling a critical gap in proteomics.
ARGO™ HT System
Proteomics at the Push of a Button
NULISA Technology
Unparalleled sensitivity and dynamic range
